-
No link between paracetamol and autism, major review finds
-
Typhoon Fung-wong floods Philippine towns, leaves 5 dead in its wake
-
France's Sarkozy says prison a 'nightmare' as prosecutors seek his release
-
Guinness maker Diageo picks new CEO after US tariffs cloud
-
China suspends 'special port fees' on US vessels
-
US senators take major step toward ending record shutdown
-
Typhoon Fung-wong leaves flooded Philippine towns in its wake
-
From Club Med to Beverly Hills: Assinie, the Ivorian Riviera
-
The 'ordinary' Arnie? Glen Powell reboots 'The Running Man'
-
Typhoon exposes centuries-old shipwreck off Vietnam port
-
French court to decide if ex-president Sarkozy can leave jail
-
China lifts sanctions on US units of South Korea ship giant Hanwha
-
Japan death row inmate's sister still fighting, even after release
-
Taylor sparks Colts to Berlin win as Pats streak hits seven
-
Dreyer, Pellegrino lift San Diego to 4-0 MLS Cup playoff win over Portland
-
Indonesia names late dictator Suharto a national hero
-
Fourth New Zealand-West Indies T20 washed out
-
Tanzania Maasai fear VW 'greenwashing' carbon credit scheme
-
Chinese businesswoman faces jail after huge UK crypto seizure
-
Markets boosted by hopes for deal to end US shutdown
-
Amazon poised to host toughest climate talks in years
-
Ex-jihadist Syrian president due at White House for landmark talks
-
Saudi belly dancers break taboos behind closed doors
-
The AI revolution has a power problem
-
Big lips and botox: In Trump's world, fashion and makeup get political
-
NBA champion Thunder rally to down Grizzlies
-
US senators reach deal that could end record shutdown
-
Weakening Typhoon Fung-wong exits Philippines after displacing 1.4 million
-
Lenny Wilkens, Basketball Hall of Famer as player and coach, dies
-
Arrive AI Growth Spurt Prompts Move to New Headquarters
-
Organto Foods Begins Trading On OTCQX(R) Best Market In The United States
-
Classover Partners with MiniMax on Breakthrough Real-Time AI Tutor, Delivering Near-Human Voice and Emotion-Aware Interaction
-
Mosaic Welcomes U.S. Decision to Add Phosphate and Potash to Critical Minerals List
-
Critical Elements Announces the Appointment of Mr. Kenneth Williamson as Director of Exploration
-
JSC UzAuto Motors Announces Tender Offer
-
Kingfisher Metals Reports 110 Meters of 0.47 g/t Gold in ~500 m step-out at Hank and Extends Gold in Soil Anomaly at Hank on the HWY 37 Project, Golden Triangle, British Columbia
-
Empire Metals Limited - Speaking at TZMI Congress
-
Sir Dave Lewis Appointed Diageo plc CEO
-
Griffin wins PGA Mexico title for third victory of the year
-
NFL makes successful return to Berlin, 35 years on
-
Lewandowski hat-trick helps Barca punish Real Madrid slip
-
George warns England against being overawed by the All Blacks
-
Lewandowski treble helps Barca beat Celta, cut gap on Real Madrid
-
Neves late show sends PSG top of Ligue 1, Strasbourg down Lille
-
Inter go top of Serie A after Napoli slip-up
-
Bezos's Blue Origin postpones rocket launch over weather
-
Hamilton upbeat despite 'nightmare' at Ferrari
-
Taylor sparks Colts to Berlin win, Pats win streak hits seven
-
Alcaraz and Zverev make winning starts at ATP Finals
-
Protests suspend opening of Nigeria heritage museum
New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
O.Karlsson--AMWN